Search Beyond News…

21Shares enables public market access to Anthropic's pre-IPO valuation through Europe's first synthetic ETP

Executive summary: 21Shares launched Europe's first synthetic ETP providing exposure to Anthropic's pre-IPO valuation via a new SPV architecture and FalconX collaboration. It bridges the gap between private AI valuations and public market liquidity, allowing retail and institutional investors in Europe to trade Anthropic's performance synthetically.

Who is involved: 21Shares, Anthropic, FalconX

Likely next (inference): Monitoring of trading volumes for the new ETP and potential regulatory scrutiny regarding synthetic exposure to private entities.

21Shares has launched a synthetic Exchange Traded Product (ETP) that allows European investors to gain exposure to the implied valuation of AI leader Anthropic before its actual IPO. Developed in partnership with FalconX and utilizing a new SPV-based architecture, the product bypasses the traditional limitations of direct private equity access. This move signals an increasing trend of financial institutions creating sophisticated derivatives to capture value from high-growth, non-public technology giants.

What's next — scenarios

Inference: scenarios and probabilities are Beyond's assessment, not reported fact.

Base Case: High adoption of synthetic AI exposure (50%)

Increased liquidity in synthetic products tracking pre-IPO tech firms, benefiting 21Shares and FalconX.

Downside: Regulatory crackdown on synthetic pre-IPO products (30%)

European regulators may limit the use of SPV architectures for synthetic exposure to non-public companies, reducing market access.

Upside: Rapid expansion of the SPV product line (20%)

21Shares uses the successful architecture to launch similar products for other AI unicorns like OpenAI.

What to watch

Timeline

Analysis — what this means

Likely next events

Sectors affected

Regulatory implications

Historical parallels

Key entities

Sources

Related cases

Browse the full archive →